Here are four takeaways:
1. Dr. Mehling presented on stem cell therapy for arthritis and joint injuries.
2. Dr. Mehling founded Mehling Orthopedics located in West Islip, N.Y., and Hackensack, N.J. He is the chief medical officer of New York City-based Blue Horizon International.
3. Currently, Blue Horizon is offering adipose-derived stem cell treatment for joint diseases at Malacky Hospital in Slovakia.
4. Dr. Mehling earned his medical degree from The Wright State University School of Medicine in Dayton, Ohio, and completed his residency at St. Joseph’s Hospital in Paterson, N.J. He completed his sports medicine fellowship at Graduate Hospital in Philadelphia.
More articles on orthopedics:
WVU Medicine opens Bone and Joint Hospital — 3 quick notes
Orthopedic surgeon to know: Dr. Brian Bear of OrthoIllinois
Danbury Orthopedics welcomes Dr. J. Albert Diaz: 4 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
